HEADER TRANSFERASE 13-MAY-04 1T8U TITLE CRYSTAL STRUCTURE OF HUMAN 3-O-SULFOTRANSFERASE-3 WITH BOUND PAP AND TITLE 2 TETRASACCHARIDE SUBSTRATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3A1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: HEPARIN-GLUCOSAMINE 3-O-SULFOTRANSFERASE, 3-OST-3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: H3-OST-3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T3 KEYWDS ALPHA-BETA MOTIF, SUBSTRATE-BINDING CLEFT, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.F.MOON,S.C.EDAVETTAL,J.M.KRAHN,E.M.MUNOZ,M.NEGISHI,R.J.LINHARDT, AUTHOR 2 J.LIU,L.C.PEDERSEN REVDAT 7 03-APR-24 1T8U 1 HETSYN REVDAT 6 29-JUL-20 1T8U 1 COMPND REMARK SEQADV HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 11-OCT-17 1T8U 1 REMARK REVDAT 4 13-JUL-11 1T8U 1 VERSN REVDAT 3 24-FEB-09 1T8U 1 VERSN REVDAT 2 26-OCT-04 1T8U 1 JRNL REVDAT 1 31-AUG-04 1T8U 0 JRNL AUTH A.F.MOON,S.C.EDAVETTAL,J.M.KRAHN,E.M.MUNOZ,M.NEGISHI, JRNL AUTH 2 R.J.LINHARDT,J.LIU,L.C.PEDERSEN JRNL TITL STRUCTURAL ANALYSIS OF THE SULFOTRANSFERASE JRNL TITL 2 (3-O-SULFOTRANSFERASE ISOFORM 3) INVOLVED IN THE JRNL TITL 3 BIOSYNTHESIS OF AN ENTRY RECEPTOR FOR HERPES SIMPLEX VIRUS 1 JRNL REF J.BIOL.CHEM. V. 279 45185 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15304505 JRNL DOI 10.1074/JBC.M405013200 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 346751.180 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 38340 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2019 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5745 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 307 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4328 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 131 REMARK 3 SOLVENT ATOMS : 358 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.29000 REMARK 3 B22 (A**2) : -5.19000 REMARK 3 B33 (A**2) : 7.47000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.940 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 52.92 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : 3OST3.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : PAP2_SO4.TOP REMARK 3 TOPOLOGY FILE 5 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1T8U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1000022456. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42327 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05400 REMARK 200 FOR THE DATA SET : 18.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.02400 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: H3-OST-3 WITH BOUND PAP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, AMMONIUM ACETATE, PEG REMARK 280 4000, PAP, PH 5.5, MICRO-SEEDING, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.96550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.96550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 40.40300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 77.26250 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 40.40300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 77.26250 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 45.96550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 40.40300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 77.26250 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 45.96550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 40.40300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 77.26250 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL UNIT IS REMARK 300 UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -58.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 42040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -124.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 80.80600 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 45.96550 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 135 REMARK 465 ARG A 274 REMARK 465 THR A 275 REMARK 465 ALA A 276 REMARK 465 GLY B 135 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 145 CG CD1 CD2 REMARK 470 ARG A 223 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 272 CG CD CE NZ REMARK 470 LYS A 345 CG CD CE NZ REMARK 470 LEU B 141 CG CD1 CD2 REMARK 470 LEU B 145 CG CD1 CD2 REMARK 470 ARG B 223 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 138 -72.08 -43.15 REMARK 500 ASP A 193 6.73 -67.82 REMARK 500 PRO B 361 175.77 -56.28 REMARK 500 HIS B 362 114.44 -167.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 702 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 252 O REMARK 620 2 ASP A 252 OD1 81.0 REMARK 620 3 THR A 256 OG1 88.0 165.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 701 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 252 O REMARK 620 2 ASP B 252 OD1 82.0 REMARK 620 3 THR B 256 OG1 97.1 163.6 REMARK 620 4 SGN C 1 O3S 85.9 72.2 91.4 REMARK 620 5 SGN C 1 O3 168.4 100.9 76.8 84.3 REMARK 620 6 IDS C 2 O6B 127.5 86.2 106.8 137.5 64.0 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1S6T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE 3-O-SULFOTRANSFERASE-1 REMARK 900 RELATED ID: 1HY3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ESTROGEN SULFOTRANSFERASE WITH BOUND REMARK 900 PAPS SUBSTRATE REMARK 900 RELATED ID: 1BFB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR WITH BOUND REMARK 900 TETRASACCHARIDE REMARK 900 RELATED ID: 1T8T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN 3-O-SULFOTRANSFERASE-3 WITH BOUND PAP DBREF 1T8U A 139 406 GB 5174465 NP_006033 139 406 DBREF 1T8U B 139 406 GB 5174465 NP_006033 139 406 SEQADV 1T8U GLY A 135 GB 5174465 CLONING ARTIFACT SEQADV 1T8U PRO A 136 GB 5174465 CLONING ARTIFACT SEQADV 1T8U ASN A 137 GB 5174465 CLONING ARTIFACT SEQADV 1T8U SER A 138 GB 5174465 CLONING ARTIFACT SEQADV 1T8U GLY B 135 GB 5174465 CLONING ARTIFACT SEQADV 1T8U PRO B 136 GB 5174465 CLONING ARTIFACT SEQADV 1T8U ASN B 137 GB 5174465 CLONING ARTIFACT SEQADV 1T8U SER B 138 GB 5174465 CLONING ARTIFACT SEQRES 1 A 272 GLY PRO ASN SER GLY THR LEU ALA LEU LEU LEU ASP GLU SEQRES 2 A 272 GLY SER LYS GLN LEU PRO GLN ALA ILE ILE ILE GLY VAL SEQRES 3 A 272 LYS LYS GLY GLY THR ARG ALA LEU LEU GLU PHE LEU ARG SEQRES 4 A 272 VAL HIS PRO ASP VAL ARG ALA VAL GLY ALA GLU PRO HIS SEQRES 5 A 272 PHE PHE ASP ARG SER TYR ASP LYS GLY LEU ALA TRP TYR SEQRES 6 A 272 ARG ASP LEU MET PRO ARG THR LEU ASP GLY GLN ILE THR SEQRES 7 A 272 MET GLU LYS THR PRO SER TYR PHE VAL THR ARG GLU ALA SEQRES 8 A 272 PRO ALA ARG ILE SER ALA MET SER LYS ASP THR LYS LEU SEQRES 9 A 272 ILE VAL VAL VAL ARG ASP PRO VAL THR ARG ALA ILE SER SEQRES 10 A 272 ASP TYR THR GLN THR LEU SER LYS ARG PRO ASP ILE PRO SEQRES 11 A 272 THR PHE GLU SER LEU THR PHE LYS ASN ARG THR ALA GLY SEQRES 12 A 272 LEU ILE ASP THR SER TRP SER ALA ILE GLN ILE GLY ILE SEQRES 13 A 272 TYR ALA LYS HIS LEU GLU HIS TRP LEU ARG HIS PHE PRO SEQRES 14 A 272 ILE ARG GLN MET LEU PHE VAL SER GLY GLU ARG LEU ILE SEQRES 15 A 272 SER ASP PRO ALA GLY GLU LEU GLY ARG VAL GLN ASP PHE SEQRES 16 A 272 LEU GLY LEU LYS ARG ILE ILE THR ASP LYS HIS PHE TYR SEQRES 17 A 272 PHE ASN LYS THR LYS GLY PHE PRO CYS LEU LYS LYS ALA SEQRES 18 A 272 GLU GLY SER SER ARG PRO HIS CYS LEU GLY LYS THR LYS SEQRES 19 A 272 GLY ARG THR HIS PRO GLU ILE ASP ARG GLU VAL VAL ARG SEQRES 20 A 272 ARG LEU ARG GLU PHE TYR ARG PRO PHE ASN LEU LYS PHE SEQRES 21 A 272 TYR GLN MET THR GLY HIS ASP PHE GLY TRP ASP GLY SEQRES 1 B 272 GLY PRO ASN SER GLY THR LEU ALA LEU LEU LEU ASP GLU SEQRES 2 B 272 GLY SER LYS GLN LEU PRO GLN ALA ILE ILE ILE GLY VAL SEQRES 3 B 272 LYS LYS GLY GLY THR ARG ALA LEU LEU GLU PHE LEU ARG SEQRES 4 B 272 VAL HIS PRO ASP VAL ARG ALA VAL GLY ALA GLU PRO HIS SEQRES 5 B 272 PHE PHE ASP ARG SER TYR ASP LYS GLY LEU ALA TRP TYR SEQRES 6 B 272 ARG ASP LEU MET PRO ARG THR LEU ASP GLY GLN ILE THR SEQRES 7 B 272 MET GLU LYS THR PRO SER TYR PHE VAL THR ARG GLU ALA SEQRES 8 B 272 PRO ALA ARG ILE SER ALA MET SER LYS ASP THR LYS LEU SEQRES 9 B 272 ILE VAL VAL VAL ARG ASP PRO VAL THR ARG ALA ILE SER SEQRES 10 B 272 ASP TYR THR GLN THR LEU SER LYS ARG PRO ASP ILE PRO SEQRES 11 B 272 THR PHE GLU SER LEU THR PHE LYS ASN ARG THR ALA GLY SEQRES 12 B 272 LEU ILE ASP THR SER TRP SER ALA ILE GLN ILE GLY ILE SEQRES 13 B 272 TYR ALA LYS HIS LEU GLU HIS TRP LEU ARG HIS PHE PRO SEQRES 14 B 272 ILE ARG GLN MET LEU PHE VAL SER GLY GLU ARG LEU ILE SEQRES 15 B 272 SER ASP PRO ALA GLY GLU LEU GLY ARG VAL GLN ASP PHE SEQRES 16 B 272 LEU GLY LEU LYS ARG ILE ILE THR ASP LYS HIS PHE TYR SEQRES 17 B 272 PHE ASN LYS THR LYS GLY PHE PRO CYS LEU LYS LYS ALA SEQRES 18 B 272 GLU GLY SER SER ARG PRO HIS CYS LEU GLY LYS THR LYS SEQRES 19 B 272 GLY ARG THR HIS PRO GLU ILE ASP ARG GLU VAL VAL ARG SEQRES 20 B 272 ARG LEU ARG GLU PHE TYR ARG PRO PHE ASN LEU LYS PHE SEQRES 21 B 272 TYR GLN MET THR GLY HIS ASP PHE GLY TRP ASP GLY HET SGN C 1 20 HET IDS C 2 16 HET SGN C 3 19 HET UAP C 4 15 HET SO4 A 700 5 HET NA A 702 1 HET NA B 701 1 HET A3P B 602 27 HET A3P B 603 27 HETNAM SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D-GLUCOPYRANOSE HETNAM IDS 2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID HETNAM UAP 4-DEOXY-2-O-SULFO-ALPHA-L-THREO-HEX-4-ENOPYRANURONIC HETNAM 2 UAP ACID HETNAM SO4 SULFATE ION HETNAM NA SODIUM ION HETNAM A3P ADENOSINE-3'-5'-DIPHOSPHATE HETSYN SGN N,O6-DISULFO-GLUCOSAMINE; 6-O-SULFO-N-SULFO-ALPHA-D- HETSYN 2 SGN GLUCOSAMINE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-ALPHA-D- HETSYN 3 SGN GLUCOSE; 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-D-GLUCOSE; HETSYN 4 SGN 2-DEOXY-6-O-SULFO-2-(SULFOAMINO)-GLUCOSE HETSYN IDS O2-SULFO-GLUCURONIC ACID; 2-O-SULFO-ALPHA-L-IDURONIC HETSYN 2 IDS ACID; 2-O-SULFO-L-IDURONIC ACID; 2-O-SULFO-IDURONIC HETSYN 3 IDS ACID HETSYN UAP 4-DEOXY-2-O-SULFO-ALPHA-L-THREO-HEX-4-ENURONIC ACID; 4- HETSYN 2 UAP DEOXY-2-O-SULFO-L-THREO-HEX-4-ENURONIC ACID; 4-DEOXY- HETSYN 3 UAP 2-O-SULFO-THREO-HEX-4-ENURONIC ACID FORMUL 3 SGN 2(C6 H13 N O11 S2) FORMUL 3 IDS C6 H10 O10 S FORMUL 3 UAP C6 H8 O9 S FORMUL 4 SO4 O4 S 2- FORMUL 5 NA 2(NA 1+) FORMUL 7 A3P 2(C10 H15 N5 O10 P2) FORMUL 9 HOH *358(H2 O) HELIX 1 1 ASN A 137 GLU A 147 1 11 HELIX 2 2 GLY A 164 ARG A 173 1 10 HELIX 3 3 SER A 191 LYS A 194 5 4 HELIX 4 4 GLY A 195 MET A 203 1 9 HELIX 5 5 SER A 218 THR A 222 5 5 HELIX 6 6 GLU A 224 SER A 233 1 10 HELIX 7 7 ASP A 244 ARG A 260 1 17 HELIX 8 8 THR A 265 PHE A 271 1 7 HELIX 9 9 TRP A 283 ILE A 288 1 6 HELIX 10 10 ILE A 290 LEU A 299 1 10 HELIX 11 11 PRO A 303 ARG A 305 5 3 HELIX 12 12 GLY A 312 ASP A 318 1 7 HELIX 13 13 ASP A 318 LEU A 330 1 13 HELIX 14 14 THR A 337 LYS A 339 5 3 HELIX 15 15 ASP A 376 GLY A 399 1 24 HELIX 16 16 ASN B 137 GLY B 148 1 12 HELIX 17 17 GLY B 164 ARG B 173 1 10 HELIX 18 18 SER B 191 ASP B 193 5 3 HELIX 19 19 LYS B 194 MET B 203 1 10 HELIX 20 20 PRO B 217 THR B 222 5 6 HELIX 21 21 GLU B 224 SER B 233 1 10 HELIX 22 22 ASP B 244 ARG B 260 1 17 HELIX 23 23 THR B 265 THR B 270 1 6 HELIX 24 24 TRP B 283 ILE B 288 1 6 HELIX 25 25 ILE B 290 LEU B 299 1 10 HELIX 26 26 PRO B 303 ARG B 305 5 3 HELIX 27 27 GLY B 312 ASP B 318 1 7 HELIX 28 28 ASP B 318 LEU B 330 1 13 HELIX 29 29 THR B 337 LYS B 339 5 3 HELIX 30 30 ASP B 376 GLY B 399 1 24 SHEET 1 A 2 SER A 149 LYS A 150 0 SHEET 2 A 2 ARG A 205 THR A 206 -1 O THR A 206 N SER A 149 SHEET 1 B 5 VAL A 178 ALA A 180 0 SHEET 2 B 5 ILE A 211 LYS A 215 1 O ILE A 211 N ARG A 179 SHEET 3 B 5 ALA A 155 GLY A 159 1 N ILE A 157 O GLU A 214 SHEET 4 B 5 LYS A 237 VAL A 242 1 O VAL A 241 N GLY A 159 SHEET 5 B 5 MET A 307 SER A 311 1 O LEU A 308 N VAL A 240 SHEET 1 C 2 PHE A 341 ASN A 344 0 SHEET 2 C 2 PHE A 349 LEU A 352 -1 O CYS A 351 N TYR A 342 SHEET 1 D 5 VAL B 178 ALA B 180 0 SHEET 2 D 5 ILE B 211 LYS B 215 1 O ILE B 211 N ARG B 179 SHEET 3 D 5 ALA B 155 GLY B 159 1 N ILE B 157 O GLU B 214 SHEET 4 D 5 LYS B 237 VAL B 242 1 O VAL B 241 N GLY B 159 SHEET 5 D 5 MET B 307 SER B 311 1 O LEU B 308 N VAL B 240 SHEET 1 E 2 PHE B 271 ASN B 273 0 SHEET 2 E 2 LEU B 278 ILE B 279 -1 O LEU B 278 N LYS B 272 SHEET 1 F 2 PHE B 341 ASN B 344 0 SHEET 2 F 2 PHE B 349 LEU B 352 -1 O CYS B 351 N TYR B 342 SSBOND 1 CYS A 351 CYS A 363 1555 1555 2.03 SSBOND 2 CYS B 351 CYS B 363 1555 1555 2.03 LINK O4 SGN C 1 C1 IDS C 2 1555 1555 1.39 LINK O4 IDS C 2 C1 SGN C 3 1555 1555 1.40 LINK O4 SGN C 3 C1 UAP C 4 1555 1555 1.39 LINK O ASP A 252 NA NA A 702 1555 1555 2.56 LINK OD1 ASP A 252 NA NA A 702 1555 1555 2.19 LINK OG1 THR A 256 NA NA A 702 1555 1555 2.24 LINK O ASP B 252 NA NA B 701 1555 1555 2.54 LINK OD1 ASP B 252 NA NA B 701 1555 1555 2.37 LINK OG1 THR B 256 NA NA B 701 1555 1555 2.31 LINK NA NA B 701 O3S SGN C 1 1555 1555 2.39 LINK NA NA B 701 O3 SGN C 1 1555 1555 2.53 LINK NA NA B 701 O6B IDS C 2 1555 1555 2.74 CISPEP 1 GLY A 159 VAL A 160 0 -0.87 CISPEP 2 GLY B 159 VAL B 160 0 -1.90 CRYST1 80.806 154.525 91.931 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012375 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006471 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010878 0.00000